Empaphage (10mg) 14 Tablets
Empagliflozin 10mg tablets for type 2 diabetes.
Empaphage (10mg) contains empagliflozin, an SGLT2 inhibitor for type 2 diabetes. It increases urinary glucose excretion. Used as monotherapy or in combination with other antidiabetic agents. Take once daily in the morning as directed.
Purpose
Treatment of type 2 diabetes mellitus as monotherapy or in combination with other antidiabetic agents.
Ingredients
Empagliflozin 10mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections.
Side Effects
Urinary tract infections, genital mycotic infections, volume depletion, nausea. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Martin DOW |
| Status | Active |
Related Products
